PRA Group Amends and Extends European Credit Facility

The latest update is out from Pra Group ( (PRAA) ).

On April 30, 2026, PRA Group Europe Holding S.à r.l. and its Swiss branch amended and restated PRA Group Inc.’s €730 million European revolving credit facility, extending its maturity from November 23, 2027 to April 30, 2031 and reducing the maximum ERC ratio from 45% to 40%. The revised agreement also permits up to €100 million of investments in or loans to joint ventures, and, as highlighted in a May 5, 2026 press release, supports the PRA 3.0 strategy by strengthening the group’s capital structure, staggering debt maturities without changing commitment or pricing, and reinforcing liquidity with no debt maturities until 2028.

The most recent analyst rating on (PRAA) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Pra Group stock, see the PRAA Stock Forecast page.

Spark’s Take on PRAA Stock

According to Spark, TipRanks’ AI Analyst, PRAA is a Neutral.

The score is held back primarily by weak financial quality (GAAP loss and persistently negative operating/free cash flow) despite improved leverage and revenue momentum. Technicals are supportive with a clear uptrend, but overbought signals temper near-term outlook. Valuation remains challenged due to negative earnings, while the latest earnings call adds a positive offset driven by strong operational/adjusted performance and de-leveraging guidance.

To see Spark’s full report on PRAA stock, click here.

More about Pra Group

PRA Group, Inc., listed on Nasdaq as PRAA, is a global leader in acquiring and collecting nonperforming loan portfolios. The company returns capital to banks and other creditors, helping expand financial services for consumers across the Americas, Europe and Australia, and works with customers to resolve their debt through its worldwide workforce.

Average Trading Volume: 494,268

Technical Sentiment Signal: Hold

Current Market Cap: $822.5M

See more data about PRAA stock on TipRanks’ Stock Analysis page.